about
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?Pathophysiological Basis for the Formation of the Tumor MicroenvironmentLeveraging oxidative stress questions in vivo: Implications and limitationsCycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseDistribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.Global microRNA depletion suppresses tumor angiogenesis.Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary resultsImaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody moleculeThe effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.Hypoxia in head and neck cancer.A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines.Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.Radiocurability is associated with interstitial fluid pressure in human tumor xenografts.Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Preparation of nucleosides derived from 2-nitroimidazole and D-arabinose, D-ribose, and D-galactose by the Vorbrüggen method and their conversion to potential precursors for tracers to image hypoxia.Retinal oxygen: from animals to humans.Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma.A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.Role of oxygenation and vascularization in drug resistance.Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia.
P2860
Q24794814-92083D34-E5B1-489C-9642-8BB0CDEC7DC2Q26752406-87A6516B-1258-482A-A27F-87A82FE4B27AQ28072581-B95428BF-AE27-4F00-AF1E-7DC9551D31ABQ30573416-64C94700-46FB-4535-8753-6F3F840967EBQ33279493-E7B6CAD2-8DBD-457F-89BC-7B80819E2297Q33671775-251166F7-050F-455C-BA6B-3D511FDD5D8BQ34587649-362EBA4E-6D4B-465D-A500-0A39E8338DF9Q34601310-E3D4E30D-2A39-4984-BA5D-EDC5E35CD6A1Q34775811-94692544-60E1-4473-B44A-1E578F571941Q36431466-3678EB82-084D-46E7-8851-5E6B8673AE3AQ36541242-C3858249-1560-43B9-80FF-38EF509FC17EQ36620703-458AC1D7-7F2F-4549-B3EA-B1F4FC7C3E6CQ37216358-D731C64E-2152-4A81-B76C-9BA84724AECFQ37399297-372241B0-5169-4027-857E-941CC01A0223Q37636056-056A5C0F-E68A-404B-A11A-F91E82501A55Q38056889-F7945860-7B68-463D-8AD9-C0F75E7CFF4DQ38730032-49CBBC90-6CBC-4C46-A8A4-B1753E9A5D21Q38767522-27797EB2-53DA-4526-9315-4FC8BE323543Q40009198-BAB9151D-56BD-491B-BFD8-1C310FCF0E7EQ40873152-DD40AC8D-BE70-48C2-904E-B1CC9FF57456Q41103222-349AD4C6-3D2A-45A5-B3E9-59BCC70C8FEBQ41834251-71C50A64-ADDB-4452-AC98-72B8AFBDF37EQ43201834-1DF96BA2-40CD-4CBD-A908-482007C69D13
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Measuring Tumor Hypoxia.
@ast
Measuring Tumor Hypoxia.
@en
type
label
Measuring Tumor Hypoxia.
@ast
Measuring Tumor Hypoxia.
@en
prefLabel
Measuring Tumor Hypoxia.
@ast
Measuring Tumor Hypoxia.
@en
P2093
P1476
Measuring Tumor Hypoxia.
@en
P2093
Dewhirst MW
Raleigh JA
P356
10.1016/S1053-4296(96)80034-8
P577
1996-01-01T00:00:00Z